呼吸系统低效率限制6分钟步行距离在系统性硬化症相关的间歇性肺部疾病
Marco Vicenzi1,2, Gaël Deboeck3, Chiara Bellocchi1,4
1Department of Clinical Sciences and Community Health, Dipartimento di Eccellenza 2023-2027, University of Milan, Milan, 20122, Italy.
Scientific reports
|October 28, 2025
概括
系统性硬化症相关的间歇性肺病 (SSc-ILD) 患者在六分钟步行测试 (6MWT) 中显示呼吸系统效率受损. 这表明SSc-ILD中的运动能力与呼吸性能有关,而不仅仅是心脏功能.
科学领域:
- 肺部病理学 肺部病理学
- 心脏病学 心脏病学
- 类风湿病学 类风湿病学
背景情况:
- 系统性硬化症相关的间歇性肺病 (SSc-ILD) 显著影响心肺健康和运动能力.
- 六分钟步行测试 (6MWT) 是体力表现的常见衡量标准,但其在SSc-ILD中充分评估心肺功能的能力有限.
研究的目的:
- 在SSc-ILD患者的6MWT期间调查心肺呼吸系统适应.
- 确定SSc-ILD的呼吸器低效率和运动能力之间的关系.
主要方法:
- 招募了23名女性SSc-ILD患者和13名健康对照 (HC).
- 参与者接受了6MWT与心肺运动测试 (CPET) 结合使用可穿戴代谢系统.
- 测量了通风器和气体交换参数,包括每分钟通风 (VE),呼吸频率 (Rf),潮体积 (Vt) 和通风器对二氧化碳 (VE/VCO2) 的相当值.
主要成果:
- 与HC相比,SSc-ILD患者在运动和恢复期间表现出较高的Rf和VE.
- 尽管步行距离相似,SSc-ILD患者在6MWT期间显示出更高的VE/VCO2.
- 在SSc-ILD中,VE/VCO2与6MWT距离负相关,表明通风效率受损.
结论:
- 在6MWT期间,SSc-ILD患者的呼吸系统效率下降.
- 在SSc-ILD中,运动能力受到心血管适应和呼吸系统性能的影响.
- 将CPET指标纳入心肺呼吸评估可以提高SSc-ILD的临床理解和评估.
更多相关视频
相关概念视频
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.2K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.2K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
3.1K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
3.1K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
3.5K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.5K
Factors Affecting Pulmonary Ventilation
2.8K
Besides the pressure difference between the external environment and the lungs, the airflow rate and ease of pulmonary ventilation are also influenced by three other factors: surface tension of the fluid in the alveoli, compliance of the lungs, and airway resistance.
Alveolar Surface Tension
The alveolar fluid lines the luminal surface of the alveoli and exerts a force called surface tension. This force is caused by the polar water molecules in the liquid being more strongly attracted to each...
Alveolar Surface Tension
The alveolar fluid lines the luminal surface of the alveoli and exerts a force called surface tension. This force is caused by the polar water molecules in the liquid being more strongly attracted to each...
2.8K
Chronic Obstructive Pulmonary Disease
2.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.2K
Acute Respiratory Failure-II
1.0K
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.0K


